CRS‘ wide range of analytical capabilities
Bioanalytics Biosimilars CRS Group

analytical capabilities

CRS collaborates with several well-established bioanalytical laboratories, providing solutions for the entire drug development process, whether small or large molecules are involved.

To this end, CRS offers a wide range of analytical capabilities. These include, among others, the characterization of New Molecular Entities (NME), the study of metabolism and metabolites, standard safety profiles formation, and biomarker research.